Recent News

• 09.03.2025 - ProMIS Neurosciences Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1b Alzheimer’s Trial of PMN310
• 08.13.2025 - ProMIS Neurosciences Announces Second Quarter 2025 Financial Results & Corporate Highlights

Recent Filings

• 09.03.2025 - 8-K Current report
• 09.03.2025 - EX-99.1 EX-99.1
• 08.22.2025 - EFFECT Notice of Effectiveness
• 08.19.2025 - 8-K Current report
• 08.14.2025 - 3 Initial statement of beneficial ownership of securities
• 08.14.2025 - 4/A Statement of changes in beneficial ownership of securities
• 08.14.2025 - 4/A Statement of changes in beneficial ownership of securities
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - 4 Statement of changes in beneficial ownership of securities